Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
98.10    -0.10 (-0.10%)
Bid:
98.20
Ask:
99.90
Spread: 1.70 (1.731%)
Market Cap: £596.64m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Syncona News

Syncona plans asset realisation strategy as net asset value falls
19 Jun 2025

Syncona plans asset realisation strategy as net asset value falls

(Alliance News) - Syncona Ltd shares climbed on Thursday as it proposed a change of investment objective to move to an orderly realisation of assets, ...

LONDON MARKET OPEN: Stocks down in run-up to UK interest rate call
19 Jun 2025

LONDON MARKET OPEN: Stocks down in run-up to UK interest rate call

(Alliance News) - Stock prices in London opened mostly in the red on Thursday, with US markets closed for Juneteenth and all eyes on the Bank of Engla...

LONDON BRIEFING: Stocks down after US Fed holds interest rates steady
19 Jun 2025

LONDON BRIEFING: Stocks down after US Fed holds interest rates steady

(Alliance News) - The FTSE 100 was called to open lower on Thursday, ahead of the Bank of England's interest rate decision at midday London time.

IN BRIEF: Syncona investee Spur reports "encouraging" drug trial data
15 May 2025

IN BRIEF: Syncona investee Spur reports "encouraging" drug trial data

Syncona Ltd - London-based investor in healthcare companies - Portfolio company Spur Therapeutics Ltd announces new data from its gene therapy program...

Syncona firm Beacon reports encouraging gene therapy trial results
7 May 2025

Syncona firm Beacon reports encouraging gene therapy trial results

(Sharecast News) - Syncona said in an update on Wednesday that its portfolio company Beacon Therapeutics has reported encouraging six-month interim re...

Syncona's Beacon Therapeutics receives positive data for XLRP therapy
7 May 2025

Syncona's Beacon Therapeutics receives positive data for XLRP therapy

(Alliance News) - Syncona Ltd on Wednesday noted its investee Beacon Therapeutics Holdings Ltd received positive data from its trial of laru-zova for ...

Syncona sees negative nine-month return despite quarterly rise
6 Feb 2025

Syncona sees negative nine-month return despite quarterly rise

(Alliance News) - Syncona Ltd on Thursday reported a negative net asset value total return for the financial year to date, despite NAV rising during i...